Autopsy report · NCT00464854
Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward
Cause of deathOther
“The study was started before the official request for protocol registration”
Life of this trial
- Registered 1 year 9 months after it had already started.
- Ran for about 1 year 2 months before it stopped.
- 100 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Assaf-Harofeh Medical Center
- Sponsor type
- Government (non-US federal)
- Conditions
- Diabetes Mellitus
- Interventions
- Glargine and insulin aspart or lispro
- Participants
- 100
- Sites
- 1
- Countries
- Israel
Trials that died the same way
- Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
“Study was redeveloped into a new protocol” - Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
“study will be started under a new modified protocol” - Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses
“The study protocol needed to be modified” - Study of Stored Tumor Samples in Young Patients With Brain Tumors
“New Protocol that replaces the current study” - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
“study revised and reinitiated under another protocol”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.